CIDRAP newsletters options
Two new infections an 9 new deaths raise the outbreak total to 130 cases, 43 of them fatal.
Those with chronic high blood pressure (BP) saw small but consequential BP increases during COVID-19.
A new study published in eClinicalMedicine analyzed 19 studies on monkeypox, which included 7,553 reported cases, among which there were 555 hospitalizations. The meta-analysis suggests monkeypox patients have a 14.1% hospitalization rate.
Americans who received an mRNA COVID-19 vaccine after SARS-CoV-2 infection are more likely to experience severe systemic adverse events (AEs) than their never-infected counterparts, according to a study published yesterday in Vaccine.
The study took place during Mali's malaria season, and findings suggest the treatment is worth pursuing.
Factors that contributed to higher death rates Blacks persisted, but adherence to protective measures widened along political lines, lifting fatalities in Whites.
The World Health Organization (WHO) monkeypox emergency committee met for the third time on Oct 20 to discuss the latest developments, concluding that the situation still warrants a public health emergency of international concern (PHEIC).
After the COVID-19 vaccine rollout to adults, Americans living in states with Republican-controlled governments were at an 11% higher risk of COVID-19 death than those in Democrat-led states, and residents of right-leaning states had a 26% higher death rate than those in states with a left-leaning voter majority.
The risk of overall infant neurodevelopment didn't change in the first year of COVID-19.
About 51% of patients with milder cases, 67% of hospitalized patients; and 74% of ICU patients had long COVID.
Officials are now reporting 128 lab-confirmed cases, up from 109, and the case-fatality rate is 28%.
First-dose COVID-19 vaccine uptake was higher in US states with worker vaccine mandates, suggesting that the requirements may have motivated even residents not covered to comply, concludes a study published late last week in JAMA Health Forum.
A report last week from the European Food Safety Authority (EFSA) suggests steps could be taken to limit the spread of antimicrobial resistance (AMR) in food-producing animals during transportation.
WHO advisers hold off on designating XBB and BQ.1 sublineages as variants of concern.
One study finds persistent racial disparities in Paxlovid prescribing through July 2022.
Nearly one third of 158 untreated COVID-19 patients experienced symptom rebound after being symptom-free for at least 2 consecutive days, finds a study of US adults published yesterday in JAMA Network Open.
An analysis of patients with Escherichia coli bloodstream infections (BSIs) found notably poorer outcomes in those with ceftriaxone-resistant infections, US researchers reported yesterday in Open Forum Infectious Diseases.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Those who were vaccinated were less likely to report such symptoms.
WHO officials say the COVID-19 pandemic's impact on essential TB services has reversed years of progress.
